Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Increased risk of lymphoid neoplasm in patients with myeloproliferative neoplasm: a study of 1,915 patients.

Haematologica - 1 Mar 2011

Rumi Elisa, Passamonti Francesco, Elena Chiara, Pietra Daniela, Arcaini Luca, Astori Cesare, Zibellini Silvia, Boveri Emanuela, Pascutto Cristiana, Lazzarino Mario

Abstract excerpt

Within a cohort of 1,915 consecutive patients with myeloproliferative neoplasm followed for a median time of 5.2 years (range 0-33.3), we investigated the occurrence of lymphoid neoplasm with the aim of defining this risk and to investigate the role of genetic predisposing factors. We identified 22 patients with myeloproliferative neoplasm who developed lymphoid neoplasm over their lifetime. We found that the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cluster Analysis
Share to Genetic Testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Janus Kinase 2

Share to Leukemia, Lymphoid

Share to Lymphoma

Share to Myeloproliferative Disorders

Source

Open in PubMed Open full text

Identifiers

PMID: 21109692
DOI: 10.3324/haematol.2010.033779
PMCID: PMC3046278

Genes

JAK2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Increased risk of lymphoid neoplasm in patients with myeloproliferative neoplasm: a study of 1,915 patients.PMID 21109692Read ↗

WHO classification of tumors of hematopoietic and lymphoid tissues, 2022 (5th edition): lymphoid tumorsSemantic proximity Read ↗

The role of the JAK2 GGCC haplotype and the TET2 gene in familial myeloproliferative neoplasms.Semantic proximity Read ↗

Myeloid Neoplasm With Germline Predisposition: A 2016 Update for Pathologists.Semantic proximity Read ↗

Genetic predisposition to lymphomas: Overview of rare syndromes and inherited familial variants.Semantic proximity Read ↗

Germ line predisposition to myeloid malignancies appearing in adulthood.Semantic proximity Read ↗

Increased risk of lymphoid neoplasms in patients with Philadelphia chromosome-negative myeloproliferative neoplasms.Semantic proximity Read ↗

World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid TissuesSemantic proximity Read ↗

[Hereditary haematological malignancies].Semantic proximity Read ↗

WHO Classification of Tumours: Pathology and Genetics. Tumours of Haematopoietic and Lymphoid TissuesSemantic proximity Read ↗

Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study.Semantic proximity Read ↗

Associated cancers in Waldenström macroglobulinemia: clues for common genetic predisposition.Semantic proximity Read ↗

Nonrandom occurrence of lymphoid cancer types in 140 families.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.